Farah Wehbe
@farahwehbe92.bsky.social
Reposted by Farah Wehbe
9/10 I want more info:
nephjc.com/news/startst...
www.nephjc.com/news/starttr...
www.nephjc.com/news/startsp...
Andreea Manolea,
Farah Wehbe,
David White
nephjc.com/news/startst...
www.nephjc.com/news/starttr...
www.nephjc.com/news/startsp...
Andreea Manolea,
Farah Wehbe,
David White
Why Can’t I Quit You: Steroid Tapering in Adults with Podocytopathies (START) — NephJC
This week, we will discuss the best schedule for tapering steroids in adult patients with podocytopathies (MCD/FSGS).
nephjc.com
September 30, 2026 at 1:27 AM
9/10 I want more info:
nephjc.com/news/startst...
www.nephjc.com/news/starttr...
www.nephjc.com/news/startsp...
Andreea Manolea,
Farah Wehbe,
David White
nephjc.com/news/startst...
www.nephjc.com/news/starttr...
www.nephjc.com/news/startsp...
Andreea Manolea,
Farah Wehbe,
David White
Reposted by Farah Wehbe
1/10 #NephJC #TenPosts #NephSly
🫘💊 START your steroids! A question we ask constantly but adult RCT data rarely answers after remission in steroid-sensitive MCD/FSGS, how long should the prednisolone taper actually be? 🧵
www.sciencedirect.com/science/arti...
🫘💊 START your steroids! A question we ask constantly but adult RCT data rarely answers after remission in steroid-sensitive MCD/FSGS, how long should the prednisolone taper actually be? 🧵
www.sciencedirect.com/science/arti...
www.sciencedirect.com
September 30, 2026 at 1:27 AM
1/10 #NephJC #TenPosts #NephSly
🫘💊 START your steroids! A question we ask constantly but adult RCT data rarely answers after remission in steroid-sensitive MCD/FSGS, how long should the prednisolone taper actually be? 🧵
www.sciencedirect.com/science/arti...
🫘💊 START your steroids! A question we ask constantly but adult RCT data rarely answers after remission in steroid-sensitive MCD/FSGS, how long should the prednisolone taper actually be? 🧵
www.sciencedirect.com/science/arti...
A nephrologist’s #WorldHeartDay reminder: the heart and kidneys are in a lifelong group chat. ❤️🫘
When one is struggling, the other usually gets the message. Protect one, and you often protect the other.
When one is struggling, the other usually gets the message. Protect one, and you often protect the other.
September 30, 2026 at 12:57 AM
A nephrologist’s #WorldHeartDay reminder: the heart and kidneys are in a lifelong group chat. ❤️🫘
When one is struggling, the other usually gets the message. Protect one, and you often protect the other.
When one is struggling, the other usually gets the message. Protect one, and you often protect the other.
Reposted by Farah Wehbe
Hey #NephJC 👋
Checkout the VA by @divyaveerssneph.bsky.social
This week we're looking at steroid weaning strategies in adults with podocytopathies (MCD/FSGS).
💊Steroids: easy to start🟢 but hard to stop 🛑.
#NephSky
www.nephjc.com/news/starttrial
Checkout the VA by @divyaveerssneph.bsky.social
This week we're looking at steroid weaning strategies in adults with podocytopathies (MCD/FSGS).
💊Steroids: easy to start🟢 but hard to stop 🛑.
#NephSky
www.nephjc.com/news/starttrial
START: The Visual Abstract — NephJC
Can steroid tapering be shorter after remission in adults with sensitive podocytopathy?
www.nephjc.com
September 28, 2026 at 11:38 AM
Hey #NephJC 👋
Checkout the VA by @divyaveerssneph.bsky.social
This week we're looking at steroid weaning strategies in adults with podocytopathies (MCD/FSGS).
💊Steroids: easy to start🟢 but hard to stop 🛑.
#NephSky
www.nephjc.com/news/starttrial
Checkout the VA by @divyaveerssneph.bsky.social
This week we're looking at steroid weaning strategies in adults with podocytopathies (MCD/FSGS).
💊Steroids: easy to start🟢 but hard to stop 🛑.
#NephSky
www.nephjc.com/news/starttrial
Reposted by Farah Wehbe
Steroids are useful (and have bad side effects) in patients with podocytopathies.
Starting is easy, but stopping can be challenging.
Are longer courses of steroids better for longer remissions? How quickly do you taper? 🐇🐢
#NephSky #NephJC
www.nephjc.com/news/startsteroidtaper
Starting is easy, but stopping can be challenging.
Are longer courses of steroids better for longer remissions? How quickly do you taper? 🐇🐢
#NephSky #NephJC
www.nephjc.com/news/startsteroidtaper
Why Can’t I Quit You: Steroid Tapering in Adults with Podocytopathies (START) — NephJC
This week, we will discuss the best schedule for tapering steroids in adult patients with podocytopathies (MCD/FSGS).
www.nephjc.com
September 28, 2026 at 2:51 PM
Steroids are useful (and have bad side effects) in patients with podocytopathies.
Starting is easy, but stopping can be challenging.
Are longer courses of steroids better for longer remissions? How quickly do you taper? 🐇🐢
#NephSky #NephJC
www.nephjc.com/news/startsteroidtaper
Starting is easy, but stopping can be challenging.
Are longer courses of steroids better for longer remissions? How quickly do you taper? 🐇🐢
#NephSky #NephJC
www.nephjc.com/news/startsteroidtaper
A very practical question in podocytopathy: how soon can we taper steroids without paying for it with more relapses? 🐇🐢
Enjoy reading! 👇🏻 #START trial #NephJC #NephSky
Enjoy reading! 👇🏻 #START trial #NephJC #NephSky
Steroids are useful (and have bad side effects) in patients with podocytopathies.
Starting is easy, but stopping can be challenging.
Are longer courses of steroids better for longer remissions? How quickly do you taper? 🐇🐢
#NephSky #NephJC
www.nephjc.com/news/startsteroidtaper
Starting is easy, but stopping can be challenging.
Are longer courses of steroids better for longer remissions? How quickly do you taper? 🐇🐢
#NephSky #NephJC
www.nephjc.com/news/startsteroidtaper
Why Can’t I Quit You: Steroid Tapering in Adults with Podocytopathies (START) — NephJC
This week, we will discuss the best schedule for tapering steroids in adult patients with podocytopathies (MCD/FSGS).
www.nephjc.com
September 28, 2026 at 3:02 PM
Reposted by Farah Wehbe
📣Hey #NephSky
We just passed 5000 #NephJC Newsletter subscribers
Will you be 5001?
Also, we can now be found at LinkedIN.
So, if you are tired of "the bad place", but don't want to miss the latest, you can follow us there as well!
www.nephjc.com/news/nephjc-on-linkedin
We just passed 5000 #NephJC Newsletter subscribers
Will you be 5001?
Also, we can now be found at LinkedIN.
So, if you are tired of "the bad place", but don't want to miss the latest, you can follow us there as well!
www.nephjc.com/news/nephjc-on-linkedin
NephJC on LinkedIn — NephJC
NephJC is now more than twelve years old- and it’s amazing to see how far a simple idea has grown. We started with a handful of nephrologists on Twitter (yeah, we still call it that) choosing a paper ...
www.nephjc.com
September 15, 2026 at 11:24 AM
📣Hey #NephSky
We just passed 5000 #NephJC Newsletter subscribers
Will you be 5001?
Also, we can now be found at LinkedIN.
So, if you are tired of "the bad place", but don't want to miss the latest, you can follow us there as well!
www.nephjc.com/news/nephjc-on-linkedin
We just passed 5000 #NephJC Newsletter subscribers
Will you be 5001?
Also, we can now be found at LinkedIN.
So, if you are tired of "the bad place", but don't want to miss the latest, you can follow us there as well!
www.nephjc.com/news/nephjc-on-linkedin
Reposted by Farah Wehbe
1/10
#NephJC #TenPostNephJC #NephSky
Can just 4 doses of an SGLT2i prevent AKI after cardiac surgery? The MERCURI-2 trial put dapagliflozin to the test. But is the benefit a treat or a trick?🫀💊
Read the article 👇
pubmed.ncbi.nlm.nih.gov/42530910/
#NephJC #TenPostNephJC #NephSky
Can just 4 doses of an SGLT2i prevent AKI after cardiac surgery? The MERCURI-2 trial put dapagliflozin to the test. But is the benefit a treat or a trick?🫀💊
Read the article 👇
pubmed.ncbi.nlm.nih.gov/42530910/
August 19, 2026 at 1:09 AM
1/10
#NephJC #TenPostNephJC #NephSky
Can just 4 doses of an SGLT2i prevent AKI after cardiac surgery? The MERCURI-2 trial put dapagliflozin to the test. But is the benefit a treat or a trick?🫀💊
Read the article 👇
pubmed.ncbi.nlm.nih.gov/42530910/
#NephJC #TenPostNephJC #NephSky
Can just 4 doses of an SGLT2i prevent AKI after cardiac surgery? The MERCURI-2 trial put dapagliflozin to the test. But is the benefit a treat or a trick?🫀💊
Read the article 👇
pubmed.ncbi.nlm.nih.gov/42530910/
Reposted by Farah Wehbe
🔍FIND-CKD🔎
💊Use of finerenone in non-diabetic CKD #NephJC #NephSky #ERA26
VA by @drbarbateba.bsky.social
www.nephjc.com/news/2026/7/17/find-ckd-the-visual-abstract
💊Use of finerenone in non-diabetic CKD #NephJC #NephSky #ERA26
VA by @drbarbateba.bsky.social
www.nephjc.com/news/2026/7/17/find-ckd-the-visual-abstract
FIND CKD: The Visual Abstract — NephJC
Is finerenone ready to move beyond diabetes? The FIND-CKD phase 3 arrived from the #ERA26 and is the first one to show kidney protection with finerenone in non-diabetic CKD. The next challenge is no...
www.nephjc.com
July 17, 2026 at 9:30 PM
🔍FIND-CKD🔎
💊Use of finerenone in non-diabetic CKD #NephJC #NephSky #ERA26
VA by @drbarbateba.bsky.social
www.nephjc.com/news/2026/7/17/find-ckd-the-visual-abstract
💊Use of finerenone in non-diabetic CKD #NephJC #NephSky #ERA26
VA by @drbarbateba.bsky.social
www.nephjc.com/news/2026/7/17/find-ckd-the-visual-abstract
Reposted by Farah Wehbe
🦵Had our Kick-off meeting today to welcome a new class of #NephJC interns (year 12 and counting).
👁️Keep an eye out for new blog and VA creators.
See if you can Catch'em All🎣
#NephSky #MedSky
@hswapnil.medsky.social @kidneyboy.bsky.social @nephroseeker.medsky.social @dramiliflores.bsky.social
👁️Keep an eye out for new blog and VA creators.
See if you can Catch'em All🎣
#NephSky #MedSky
@hswapnil.medsky.social @kidneyboy.bsky.social @nephroseeker.medsky.social @dramiliflores.bsky.social
June 28, 2026 at 8:29 PM
🦵Had our Kick-off meeting today to welcome a new class of #NephJC interns (year 12 and counting).
👁️Keep an eye out for new blog and VA creators.
See if you can Catch'em All🎣
#NephSky #MedSky
@hswapnil.medsky.social @kidneyboy.bsky.social @nephroseeker.medsky.social @dramiliflores.bsky.social
👁️Keep an eye out for new blog and VA creators.
See if you can Catch'em All🎣
#NephSky #MedSky
@hswapnil.medsky.social @kidneyboy.bsky.social @nephroseeker.medsky.social @dramiliflores.bsky.social
Grateful to share our case report,Fatal Tea Tree Oil Intoxication,published in The American Journal of Medicine.
The 1st documented fatal TTO ingestion case,complicated by multi-organ toxicity and AKI requiring hemodialysis.
Thankful to my colleagues for their support.
www.amjmed.com/article/S000...
The 1st documented fatal TTO ingestion case,complicated by multi-organ toxicity and AKI requiring hemodialysis.
Thankful to my colleagues for their support.
www.amjmed.com/article/S000...
Fatal tea tree oil intoxication: A case report
A 35-year-old woman with schizophrenia, daily methamphetamine use, and a recent psychiatric
admission for psychosis, presented after ingesting ∼ 30 mL of tea tree oil the night
before, believing it wo...
www.amjmed.com
April 30, 2026 at 7:28 PM
Grateful to share our case report,Fatal Tea Tree Oil Intoxication,published in The American Journal of Medicine.
The 1st documented fatal TTO ingestion case,complicated by multi-organ toxicity and AKI requiring hemodialysis.
Thankful to my colleagues for their support.
www.amjmed.com/article/S000...
The 1st documented fatal TTO ingestion case,complicated by multi-organ toxicity and AKI requiring hemodialysis.
Thankful to my colleagues for their support.
www.amjmed.com/article/S000...
Reposted by Farah Wehbe
More pictures from the Ottawa #NephMadness party
The fellows really did get quite animated for their second bracket 😂
The fellows really did get quite animated for their second bracket 😂
March 11, 2026 at 2:19 PM
More pictures from the Ottawa #NephMadness party
The fellows really did get quite animated for their second bracket 😂
The fellows really did get quite animated for their second bracket 😂
Reposted by Farah Wehbe
So proud that the TOH Nephrology Fellows be sharing the Canadian trophy with Queen’s for the Canadian Kidney Cup!!! 🫘🏆 @nephmadness.bsky.social @drflashheart.bsky.social #NephSky
April 22, 2026 at 12:06 PM
So proud that the TOH Nephrology Fellows be sharing the Canadian trophy with Queen’s for the Canadian Kidney Cup!!! 🫘🏆 @nephmadness.bsky.social @drflashheart.bsky.social #NephSky
Reposted by Farah Wehbe
Cuffless BP review with @farahwehbe92.bsky.social - incoming HT fellow in Ottawa, with tables, and details of technology, devices and ongoing trials
pubmed.ncbi.nlm.nih.gov/41460057/
thanks to @profdg.bsky.social for the invite!
pubmed.ncbi.nlm.nih.gov/41460057/
thanks to @profdg.bsky.social for the invite!
Cuffless blood pressure in 2025: from promise to practice: a narrative review - PubMed
Cuffless wearables may be used as adjuncts to surface patterns and support engagement; diagnosis and treatment decisions must be confirmed with validated upper-arm measurements. A pragmatic "good-enough" checklist includes stable calibration over weeks, accuracy across dynamic states and subgroups, …
pubmed.ncbi.nlm.nih.gov
January 7, 2026 at 11:13 PM
Cuffless BP review with @farahwehbe92.bsky.social - incoming HT fellow in Ottawa, with tables, and details of technology, devices and ongoing trials
pubmed.ncbi.nlm.nih.gov/41460057/
thanks to @profdg.bsky.social for the invite!
pubmed.ncbi.nlm.nih.gov/41460057/
thanks to @profdg.bsky.social for the invite!
Excited to share our review in #KIReports – a real milestone for me!
#CKD at the Crossroads: From Failure to Future Therapies
1️⃣ Current & emerging CKD therapies
2️⃣ Why proven treatments are still underused
3️⃣ Practical checklist to help clinicians implement kidney protective therapies in practice
#CKD at the Crossroads: From Failure to Future Therapies
1️⃣ Current & emerging CKD therapies
2️⃣ Why proven treatments are still underused
3️⃣ Practical checklist to help clinicians implement kidney protective therapies in practice
#CKDs at the Crossroads: From Failures to #Future #Therapies
https://doi.org/10.1016/j.ekir.2025.09.050
#KIRReview
https://doi.org/10.1016/j.ekir.2025.09.050
#KIRReview
January 25, 2026 at 3:34 AM
Excited to share our review in #KIReports – a real milestone for me!
#CKD at the Crossroads: From Failure to Future Therapies
1️⃣ Current & emerging CKD therapies
2️⃣ Why proven treatments are still underused
3️⃣ Practical checklist to help clinicians implement kidney protective therapies in practice
#CKD at the Crossroads: From Failure to Future Therapies
1️⃣ Current & emerging CKD therapies
2️⃣ Why proven treatments are still underused
3️⃣ Practical checklist to help clinicians implement kidney protective therapies in practice
Honored to collaborate on this narrative review on cuffless blood pressure monitoring — a rapidly evolving space with huge clinical potential. Big thanks to @hswapnil.medsky.social for the opportunity!
Cuffless BP review with @farahwehbe92.bsky.social - incoming HT fellow in Ottawa, with tables, and details of technology, devices and ongoing trials
pubmed.ncbi.nlm.nih.gov/41460057/
thanks to @profdg.bsky.social for the invite!
pubmed.ncbi.nlm.nih.gov/41460057/
thanks to @profdg.bsky.social for the invite!
Cuffless blood pressure in 2025: from promise to practice: a narrative review - PubMed
Cuffless wearables may be used as adjuncts to surface patterns and support engagement; diagnosis and treatment decisions must be confirmed with validated upper-arm measurements. A pragmatic "good-enough" checklist includes stable calibration over weeks, accuracy across dynamic states and subgroups, …
pubmed.ncbi.nlm.nih.gov
January 25, 2026 at 3:19 AM
Honored to collaborate on this narrative review on cuffless blood pressure monitoring — a rapidly evolving space with huge clinical potential. Big thanks to @hswapnil.medsky.social for the opportunity!